Skip to main content
Clinical Trials/NCT05996965
NCT05996965
Recruiting
N/A

Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device (HemoVista™) in the Clinical Filed

Seoul National University Hospital1 site in 1 country40 target enrollmentNovember 21, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular Complication
Sponsor
Seoul National University Hospital
Enrollment
40
Locations
1
Primary Endpoint
degree of agreement in cardiac output
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

In patients undergoing surgery under general anesthesia, the clinical utility of non-invasive hemodynamic status monitoring equipment using HemoVista is compared with invasive hemodynamic status monitoring equipment FloTrac.

Detailed Description

For patients who are scheduled to monitor invasive blood pressure, invasive hemodynamic monitoring using FloTrac and additional HemoVista sensors are attached and output data are obtained at the same time during general anesthesia. FloTrac is used to conduct conventional anesthesia and fluid therapy, and the accuracy of HemoVista, a non-invasive hemodynamic monitoring equipment, is compared through prospective observational studies.

Registry
clinicaltrials.gov
Start Date
November 21, 2023
End Date
December 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hee-Soo Kim

professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 20 or older who undergo surgery under general anesthesia for more than two hours
  • invasive close hemodynamic monitoring with FloTrac is needed

Exclusion Criteria

  • problems in site where HemoVista is attached

Outcomes

Primary Outcomes

degree of agreement in cardiac output

Time Frame: during surgery

degree of agreement in cardiac output between HemoVista and FloTrac

Study Sites (1)

Loading locations...

Similar Trials